Investor Relations

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.


All Releases
View Summary PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award
Nov 21, 2014
PDF 10.5 KB Add to Briefcase
View Summary Spinal Muscular Atrophy Program Enters Phase 1b/2a Trial in Patients with SMA
Nov 19, 2014
PDF 10.3 KB Add to Briefcase
View Summary PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nov 17, 2014
PDF 7.4 KB Add to Briefcase
View Summary PTC Therapeutics Appoints Dr. Tuyen Ong SVP, Head of Clinical Development and Translational Research
Nov 17, 2014
PDF 46.7 KB Add to Briefcase
View Summary PTC Therapeutics Recognized for Outstanding Innovation at the 2014 Rare & Orphan Advocacy and Research (ROAR) Awards
Nov 14, 2014
PDF 7.7 KB Add to Briefcase
View Summary PTC Therapeutics to Webcast Upcoming Science Day and Investor Conferences
Nov 13, 2014
PDF 7.9 KB Add to Briefcase
View Summary PTC Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
Nov 6, 2014
PDF 22.4 KB Add to Briefcase
View Summary PTC Therapeutics Expands Access For Translarna™ (Ataluren)
Nov 3, 2014
PDF 13.2 KB Add to Briefcase
View Summary PTC Therapeutics to Present at the Credit Suisse 23rd Annual Healthcare Conference
Oct 29, 2014
PDF 7.2 KB Add to Briefcase
View Summary Translarna™ Phase 2b Data Published in Muscle & Nerve
Oct 27, 2014
PDF 61.8 KB Add to Briefcase
View Summary PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2014 Financial Results
Oct 23, 2014
PDF 8.5 KB Add to Briefcase
View Summary PTC Therapeutics Announces Pricing of Public Offering of Common Stock
Oct 9, 2014
PDF 45.4 KB Add to Briefcase
View Summary PTC Therapeutics Announces Proposed Public Offering of Common Stock
Oct 8, 2014
PDF 45.5 KB Add to Briefcase
View Summary PTC Therapeutics to Present at the Leerink Partners Rare Disease Roundtable
Sep 24, 2014
PDF 43.5 KB Add to Briefcase
View Summary PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635©(4)
Sep 24, 2014
PDF 43.6 KB Add to Briefcase
View Summary PTC Therapeutics Expands Global Presence in Support of Translarna™ Launch in Duchenne Muscular Dystrophy
Sep 17, 2014
PDF 84.2 KB Add to Briefcase
View Summary PTC THERAPEUTICS COMPLETES ENROLLMENT OF LANDMARK TRIAL IN DUCHENNE MUSCULAR DYSTROPHY
Sep 9, 2014
PDF 11.1 KB Add to Briefcase
View Summary PTC THERAPEUTICS TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES
Aug 20, 2014
PDF 6.8 KB Add to Briefcase
View Summary PTC Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
Aug 7, 2014
PDF 57.4 KB Add to Briefcase
View Summary Orally delivered compounds, which selectively modify RNA splicing prevent deficits in mouse models of Spinal Muscular Atrophy
Aug 7, 2014
PDF 11.7 KB Add to Briefcase
Showing 1-20 of 96 Page: 1 2 3 4 5  Next 20
Add to Briefcase = add release to Briefcase